Gynecologic cancers associated with Lynch syndrome/HNPCC

Clinical and Translational Oncology

Volumn 10, Issue 6, 2008, Pages 313-317

  Schmeler, Kathleen M ^a   Lu, Karen H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Endometrial cancer; HNPCC; Lynch syndrome; Ovarian cancer; Risk reducing surgery

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CA 125 ANTIGEN; DNA; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MISMATCH REPAIR PROTEIN; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CLINICAL TRIAL; COLORECTAL CANCER; DISEASE ASSOCIATION; EARLY MENOPAUSE; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; FAMILIAL CANCER; FEMALE; GENE MUTATION; GERM LINE; GYNECOLOGIC CANCER; HUMAN; HYSTERECTOMY; OVARY CANCER; PERITONEUM CANCER; PRACTICE GUIDELINE; RISK REDUCTION; SALPINGOOOPHORECTOMY; TRANSVAGINAL ECHOGRAPHY; ADULT; COLORECTAL TUMOR; FEMALE GENITAL TRACT TUMOR; GENETIC PREDISPOSITION; MIDDLE AGED; REVIEW;

ADULT; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED;

EID: 51649130200     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-008-0206-9     Document Type: Article

References (48)

1. Leach FS, Nicolaides NC, Papadopoulos N et al (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215-1225
2. Fishel R, Lescoe MK, Rao MR et al (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027-1038
3. Papadopoulos N, Nicolaides NC, Wei YF et al (1994) Mutation of a mutL homolog in hereditary colon cancer. Sciene 263:1625-1629
4. Kolodner RD, Tytell JD, Schmeits JL et al (1999) Germ-line msh6 mutations in colorectal cancer families. Cancer Res 59:5068-5074
5. Aarnio M, Sankila R, Pukkala E et al (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81:214-218
6. Dunlop MG, Farrington SM, Carothers AD et al (1997) Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 6:105-110
7. Warthin A (1913) Heredity with reference to carcinoma as shown by the study of the cases examined in the pathological library of the University of Michigan. Arch Intern Med 12:546-555
8. Lynch HT, Krush AJ (1971) Cancer family "G" revisited: 1895-1970. Cancer 27:1505-1511
9. Douglas JA, Gruber SB, Meister KA et al (2005) History and molecular genetics of Lynch syndrome in family G: A century later. JAMA 294:2195-2202
10. Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116:1453-1456
11. Boland CR, Thibodeau SN, Hamilton SR et al (1998). A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257
12. Lancaster JM, Powell CB, Kauff ND et al (2007) Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol 107:159-162
13. Boks DE, Trujillo AP, Voogd AC et al (2002) Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer. Int J Cancer 102:198-200
14. Broaddus RR, Lynch HT, Chen LM et al (2006) Pathologic features of endometrial carcinoma associated with HNPCC: A comparison with sporadic endometrial carcinoma. Cancer 106:87-94
15. Dove-Edwin I, Boks D, Goff S et al (2002) The cutcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma. Cancer 94:1708-1712
16. Rijcken FE, Mourits MJ, Kleibeuker JH et al (2003) Gynecologic screening in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 91:74-80
17. Lecuru F, Metzger U, Scarabin C et al (2007) Hysteroscopic findings in women at risk of HNPCC. Results of a prospective observational study. Fam Cancer 6:295-299
18. Renkonen-Sinisalo L, Butzow R, Leminen A et al (2007) Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome. Int J Cancer 120:821-824
19. Burke W, Petersen G, Lynch P et al (1997) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA 277:915-919
20. Lindor NM, Petersen GM, Hadley DW et al (2006) Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 296:1507-1517
21. [No authors listed] (1983) Oral contraceptive use and the risk of endometrial cancer. The Centers for Disease Control Cancer and Steroid Hormone Study. JAMA 249:1600-1604
22. [No authors listed] (1983) Oral contraceptive use and the risk of ovarian cancer. The Centers for Disease Control Cancer and Steroid Hormone Study. JAMA 249:1596-1599
23. [No authors listed] (1987) Combination oral contraceptive use and the risk of endometrial cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. JAMA 257:796-800
24. Randall TC, Kurman RJ (1997) Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 90:434-440
25. Wildemeersch D, Dhont M (2003) Treatment of nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system. Am J Obstet Gynecol 188:1297-1298
26. Horn LC, Schnurrbusch U, Bilek K et al (2004) Risk of progression in complex and atypical endometrial hyperplasia: Clinicopathologic analysis in cases with and without progestogen treatment. Int J Gynecol Cancer 14:348-353
27. Schmeler KM, Lynch HT, Chen LM et al (2006) Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 354:261-269
28. Vasen HF, Stormorken A, Menko FH et al (2001) MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 19:4074-4080
29. Watson P, Butzow R, Lynch HT, et al (2001) The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 82:223-228
30. Rebbeck TR (2002) Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers. Eur J Cancer 38(Suppl 6):S15-S17
31. Kauff ND, Satagopan JM, Robson ME, et al (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346:1609-1615
32. Lu KH, Garber JE, Cramer DW et al (2000) Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy. J Clin Oncol 18:2728-2732
33. Colgan TJ, Murphy J, Cole DE et al (2001) Occult carcinoma in prophylactic oophorectomy specimens: Prevalence and association with BRCA germline mutation status. Am J Surg Pathol 25:1283-1289
34. Powell CB, Kenley E, Chen LM et al (2005) Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: Role of serial sectioning in the detection of occult malignancy. J Clin Oncol 23:127-132
35. Schmeler KM, Sun CC, Bodurka DC et al (2006) Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations. Obstet Gynecol 108:515-520
36. Chung L, Broaddus R, Crozier M et al (2003) Unexpected endometrial cancer at prophylactic hysterectomy in a woman with hereditary nonpolyposis colon cancer. Obstet Gynecol 02:1152-1155
37. Daniels M; Schmeler KWP, Chen L et al (2007) Clinical and pathologic features of ovarian cancer in women with Lynch syndrome mutations. Proceedings of the 2nd Biennial Scientific Meeting of International Society of Gastrointestinal Hereditary Tumours (InSiGHT, Japan)
38. Lynch HT, Harris RE, Lynch PM et al (1977) Role of heredity in multiple primary cancer. Cancer 40:1849-1854
39. Mecklin JP, Jarvinen HJ (1986) Clinical features of colorectal carcinoma in cancer family syndrome. Dis Colon Rectum 29:160-164
40. Lu KH, Dinh M, Kohlmann W et al (2005) Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol 105:569-574
41. Kovac SR (2000) Hysterectomy outcomes in patients with similar indications. Obstet Gynecol 95:787-793
42. Weber AM, Lee JC (1996) Use of alternative techniques of hysterectomy in Ohio, 1988-1994. N Engl J Med 335:483-489
43. Geodno JA Jr., Powers TW, Harris VD (1995) Ureteral injury in gynecologic surgery: A ten-year review in a community hospital. Am J Obstet Gynecol 172:1817-1820; discussion 1820-1822
44. Prior JC, Vigna YM, Wark JD et al (1997) Premenopausal ovariectomy-related bone loss: A randomized, double-blind, one-year trial of conjugated estrogen or medroxyprogesterone acetate. J Bone Miner Res 12:1851-1863
45. Graziottin A, Basson R (2004). Sexual dysfunction in women with premature menopause. Menopause 11:766-777
46. Speroff L GR, Kase NG (1999) Menopause and the perimenopausal transition. In: Clinical Gynecologic Endocrinology and Infertility. Lippincott Williams and Wilkins, Baltimore, p. 662-667
47. Anderson GL, Limacher M, Assaf AR et al (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. JAMA 291:1701-1712
48. Chen LM, Yang KY, Little SE et al (2007) Gynecologic cancer prevention in lynch syndrome/hereditary nonpolyposis colorectal cancer families. Obstet Gynecol 110:18-25